Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Iovance Biotherapeutics to Present at Two Upcoming September Conferences

Posted on: 05 Sep 17

SAN CARLOS, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it will webcast a business overview and update by Dr. Maria Fardis, PhD, MBA, Chief Executive Officer of Iovance Biotherapeutics at the following upcoming investor conferences:

  • Rodman & Renshaw 19th Annual Global Investment Conference in New York, NY on Monday, September 11, 2017 at 11:40 a.m. ET
  • 2017 Cantor Fitzgerald Global Healthcare Conference in New York, NY on Monday, September 25, 2017 at 8:00 a.m. ET

A live audio webcast of both presentations will be available by visiting the Investors section Iovance Biotherapeutics' website at A replay of the webcast will be archived on Iovance Biotherapeutics’ website for 30 days following the presentation.

About Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on the development of cancer immunotherapy products for the treatment of various cancers. The Company's lead product candidate is an adoptive cell therapy using tumor-infiltrating lymphocyte (TIL) technology being investigated for the treatment of patients with metastatic melanoma, recurrent and/or metastatic squamous cell carcinoma of the head and neck and recurrent and metastatic or persistent cervical cancer. For more information, please visit

CONTACT: Investor Relations Contact: Sarah McCabe Stern Investor Relations, Inc. 212-362-1200 Media Relations Contact: Evan Smith/Kotaro Yoshida FTI Consulting 212-850-5622/212-850-5690 GlobeNewswire

Last updated on: 05/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.